Share Price and Basic Stock Data
Last Updated: January 17, 2026, 12:54 pm
| PEG Ratio | 0.96 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Aarti Surfactants Ltd operates within the specialty chemicals sector, focusing on surfactants. The company recorded a price of ₹380 and a market capitalization of ₹322 Cr. Over the last few years, Aarti Surfactants demonstrated a steady upward trend in sales, rising from ₹326 Cr in March 2020 to ₹601 Cr in March 2023, before achieving ₹659 Cr in March 2025. The trailing twelve months (TTM) revenue stood at ₹760 Cr, indicating robust sales momentum. Quarterly sales figures fluctuated, with the highest quarterly sales of ₹215.90 Cr reported for June 2025, reflecting a recovery from the lower sales of ₹133.55 Cr in December 2022. This trend illustrates the company’s ability to adapt to market demands and optimize its production capabilities, contributing to a sizeable sales growth trajectory.
Profitability and Efficiency Metrics
The profitability of Aarti Surfactants has shown variability, with operating profit margins (OPM) fluctuating between 2.47% and 12.06% over the last few quarters. For the fiscal year ending March 2025, OPM stood at 6.88%, down from 11% in March 2024. Net profit for March 2025 was reported at ₹15 Cr, with earnings per share (EPS) at ₹17.20. The interest coverage ratio (ICR) was reported at 3.93x, indicating that the company is comfortably managing its interest obligations. However, the return on equity (ROE) stood at a modest 5.14%, suggesting room for improvement in generating returns for shareholders. The cash conversion cycle (CCC) span of 71 days reflects operational efficiency but also highlights potential areas for streamlining to enhance liquidity.
Balance Sheet Strength and Financial Ratios
Aarti Surfactants’ balance sheet reveals a total debt of ₹118 Cr against reserves of ₹228 Cr, indicating a conservative leverage strategy with a total debt-to-equity ratio of 0.37x as of March 2025. The current ratio stands at 1.35, suggesting that the company is in a sound position to meet its short-term liabilities. The book value per share increased to ₹274.78, showcasing a solid equity base. However, the price-to-book value ratio of 1.46x suggests the stock may be trading at a premium relative to its net assets. Furthermore, the company’s working capital days of 36 indicate effective management of its operational liquidity. The overall financial ratios present a balanced picture, but the company’s moderate ROCE of 8.50% points to the need for enhanced capital efficiency.
Shareholding Pattern and Investor Confidence
Aarti Surfactants’ shareholding structure is characterized by a significant promoter stake of 49.92%, indicating strong management control and alignment with shareholder interests. The public holds 49.26% of the shares, reflecting a relatively high level of retail interest. However, foreign institutional investors (FIIs) have a negligible presence at 0%, which may signal a lack of international investor confidence in the stock. Domestic institutional investors (DIIs) hold 0.80%, suggesting limited institutional backing. The total number of shareholders decreased from 40,877 in December 2022 to 37,015 by September 2025, which may raise concerns about investor sentiment. The stability in promoter holdings contrasted with the decline in public shareholders could imply a need for the company to enhance its outreach and investor relations to boost confidence.
Outlook, Risks, and Final Insight
Looking ahead, Aarti Surfactants faces both opportunities and challenges. The ongoing demand for specialty chemicals presents a growth avenue, particularly as the company has demonstrated the ability to scale sales effectively. However, profitability pressures, evident from the declining OPM and fluctuating net profits, pose significant risks. Additionally, the company’s dependency on domestic markets and limited foreign institutional interest may inhibit its growth potential. Risks associated with raw material price volatility and operational inefficiencies could further impact margins. For Aarti Surfactants to capitalize on growth opportunities, it must focus on enhancing operational efficiencies and improving profitability metrics. Strengthening investor relations could also attract institutional interest, bolstering its market position.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 362 Cr. | 39.4 | 75.0/39.0 | 22.5 | 20.5 | 1.01 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 29.0 Cr. | 59.0 | 88.8/55.0 | 13.9 | 89.6 | 1.69 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 46.9 Cr. | 689 | 907/600 | 21.6 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,317 Cr. | 73.2 | 111/68.2 | 22.0 | 22.0 | 0.68 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 570 Cr. | 228 | 393/225 | 20.4 | 93.8 | 1.09 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,586.60 Cr | 681.35 | 63.08 | 182.97 | 0.46% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 151.77 | 133.55 | 157.84 | 148.70 | 143.86 | 138.75 | 158.55 | 143.41 | 150.84 | 162.78 | 202.05 | 215.90 | 179.17 |
| Expenses | 143.00 | 119.98 | 143.94 | 133.90 | 127.60 | 122.02 | 144.21 | 133.79 | 147.12 | 153.89 | 182.36 | 204.27 | 169.83 |
| Operating Profit | 8.77 | 13.57 | 13.90 | 14.80 | 16.26 | 16.73 | 14.34 | 9.62 | 3.72 | 8.89 | 19.69 | 11.63 | 9.34 |
| OPM % | 5.78% | 10.16% | 8.81% | 9.95% | 11.30% | 12.06% | 9.04% | 6.71% | 2.47% | 5.46% | 9.75% | 5.39% | 5.21% |
| Other Income | 0.09 | 0.06 | 0.09 | 0.03 | 0.03 | 0.03 | 0.05 | 0.49 | 6.21 | -0.16 | 1.14 | 0.04 | 0.06 |
| Interest | 3.74 | 4.16 | 3.91 | 3.32 | 3.66 | 3.65 | 3.41 | 2.57 | 2.60 | 3.12 | 3.26 | 3.28 | 2.80 |
| Depreciation | 4.06 | 4.01 | 3.93 | 3.95 | 3.85 | 4.02 | 4.21 | 4.23 | 4.31 | 4.40 | 4.41 | 4.35 | 4.41 |
| Profit before tax | 1.06 | 5.46 | 6.15 | 7.56 | 8.78 | 9.09 | 6.77 | 3.31 | 3.02 | 1.21 | 13.16 | 4.04 | 2.19 |
| Tax % | 69.81% | 27.11% | 23.90% | 30.56% | 45.90% | 26.40% | 31.17% | 32.93% | 40.07% | 33.88% | 26.22% | 27.23% | 29.22% |
| Net Profit | 0.32 | 3.98 | 4.69 | 5.25 | 4.74 | 6.68 | 4.65 | 2.22 | 1.81 | 0.80 | 9.72 | 2.94 | 1.56 |
| EPS in Rs | 0.38 | 4.68 | 5.52 | 6.18 | 5.58 | 7.86 | 5.50 | 2.62 | 2.14 | 0.95 | 11.49 | 3.48 | 1.84 |
Last Updated: December 28, 2025, 10:35 am
Below is a detailed analysis of the quarterly data for Aarti Surfactants Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 179.17 Cr.. The value appears to be declining and may need further review. It has decreased from 215.90 Cr. (Jun 2025) to 179.17 Cr., marking a decrease of 36.73 Cr..
- For Expenses, as of Sep 2025, the value is 169.83 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 204.27 Cr. (Jun 2025) to 169.83 Cr., marking a decrease of 34.44 Cr..
- For Operating Profit, as of Sep 2025, the value is 9.34 Cr.. The value appears to be declining and may need further review. It has decreased from 11.63 Cr. (Jun 2025) to 9.34 Cr., marking a decrease of 2.29 Cr..
- For OPM %, as of Sep 2025, the value is 5.21%. The value appears to be declining and may need further review. It has decreased from 5.39% (Jun 2025) to 5.21%, marking a decrease of 0.18%.
- For Other Income, as of Sep 2025, the value is 0.06 Cr.. The value appears strong and on an upward trend. It has increased from 0.04 Cr. (Jun 2025) to 0.06 Cr., marking an increase of 0.02 Cr..
- For Interest, as of Sep 2025, the value is 2.80 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.28 Cr. (Jun 2025) to 2.80 Cr., marking a decrease of 0.48 Cr..
- For Depreciation, as of Sep 2025, the value is 4.41 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.35 Cr. (Jun 2025) to 4.41 Cr., marking an increase of 0.06 Cr..
- For Profit before tax, as of Sep 2025, the value is 2.19 Cr.. The value appears to be declining and may need further review. It has decreased from 4.04 Cr. (Jun 2025) to 2.19 Cr., marking a decrease of 1.85 Cr..
- For Tax %, as of Sep 2025, the value is 29.22%. The value appears to be increasing, which may not be favorable. It has increased from 27.23% (Jun 2025) to 29.22%, marking an increase of 1.99%.
- For Net Profit, as of Sep 2025, the value is 1.56 Cr.. The value appears to be declining and may need further review. It has decreased from 2.94 Cr. (Jun 2025) to 1.56 Cr., marking a decrease of 1.38 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.84. The value appears to be declining and may need further review. It has decreased from 3.48 (Jun 2025) to 1.84, marking a decrease of 1.64.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:21 am
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 326 | 466 | 576 | 601 | 590 | 659 | 760 |
| Expenses | 302 | 420 | 543 | 554 | 528 | 617 | 710 |
| Operating Profit | 24 | 46 | 32 | 48 | 62 | 42 | 50 |
| OPM % | 7% | 10% | 6% | 8% | 11% | 6% | 7% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 8 | 1 |
| Interest | 10 | 10 | 11 | 15 | 14 | 12 | 12 |
| Depreciation | 11 | 12 | 12 | 15 | 16 | 17 | 18 |
| Profit before tax | 3 | 23 | 9 | 18 | 32 | 21 | 21 |
| Tax % | 29% | 6% | 41% | 29% | 34% | 30% | |
| Net Profit | 2 | 22 | 5 | 13 | 21 | 15 | 15 |
| EPS in Rs | 2.46 | 25.45 | 6.46 | 14.94 | 25.22 | 17.19 | 17.76 |
| Dividend Payout % | 0% | 11% | 0% | 0% | 0% | 6% |
YoY Net Profit Growth
| Year | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 1000.00% | -77.27% | 160.00% | 61.54% | -28.57% |
| Change in YoY Net Profit Growth (%) | 0.00% | -1077.27% | 237.27% | -98.46% | -90.11% |
Aarti Surfactants Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 5% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 41% |
| 3 Years: | 28% |
| TTM: | -31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -2% |
| 3 Years: | -17% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 8% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 2:01 pm
Balance Sheet
Last Updated: December 4, 2025, 2:16 am
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 103 | 125 | 128 | 160 | 210 | 224 | 228 |
| Borrowings | 109 | 152 | 162 | 149 | 99 | 110 | 118 |
| Other Liabilities | 42 | 102 | 105 | 86 | 105 | 134 | 135 |
| Total Liabilities | 262 | 387 | 402 | 404 | 422 | 477 | 490 |
| Fixed Assets | 151 | 187 | 173 | 207 | 208 | 204 | 201 |
| CWIP | 14 | 20 | 52 | 8 | 8 | 15 | 29 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 97 | 180 | 178 | 188 | 206 | 259 | 260 |
| Total Assets | 262 | 387 | 402 | 404 | 422 | 477 | 490 |
Below is a detailed analysis of the balance sheet data for Aarti Surfactants Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Reserves, as of Sep 2025, the value is 228.00 Cr.. The value appears strong and on an upward trend. It has increased from 224.00 Cr. (Mar 2025) to 228.00 Cr., marking an increase of 4.00 Cr..
- For Borrowings, as of Sep 2025, the value is 118.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 110.00 Cr. (Mar 2025) to 118.00 Cr., marking an increase of 8.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 135.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 134.00 Cr. (Mar 2025) to 135.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 490.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 477.00 Cr. (Mar 2025) to 490.00 Cr., marking an increase of 13.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 201.00 Cr.. The value appears to be declining and may need further review. It has decreased from 204.00 Cr. (Mar 2025) to 201.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 14.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 260.00 Cr.. The value appears strong and on an upward trend. It has increased from 259.00 Cr. (Mar 2025) to 260.00 Cr., marking an increase of 1.00 Cr..
- For Total Assets, as of Sep 2025, the value is 490.00 Cr.. The value appears strong and on an upward trend. It has increased from 477.00 Cr. (Mar 2025) to 490.00 Cr., marking an increase of 13.00 Cr..
Notably, the Reserves (228.00 Cr.) exceed the Borrowings (118.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | -85.00 | -106.00 | -130.00 | -101.00 | -37.00 | -68.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 20 | 43 | 35 | 40 | 43 | 42 |
| Inventory Days | 83 | 76 | 60 | 60 | 81 | 92 |
| Days Payable | 28 | 81 | 56 | 44 | 55 | 63 |
| Cash Conversion Cycle | 75 | 38 | 38 | 55 | 69 | 71 |
| Working Capital Days | -1 | 3 | 16 | 20 | 40 | 36 |
| ROCE % | 13% | 7% | 11% | 15% | 8% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 17.20 | 26.63 | 16.64 | 7.25 | 28.53 |
| Diluted EPS (Rs.) | 17.19 | 25.16 | 16.47 | 7.25 | 28.53 |
| Cash EPS (Rs.) | 37.67 | 44.13 | 35.50 | 23.65 | 44.62 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 274.78 | 257.64 | 211.58 | 179.20 | 174.90 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 274.78 | 257.64 | 211.58 | 179.20 | 174.90 |
| Revenue From Operations / Share (Rs.) | 778.53 | 696.75 | 757.16 | 758.81 | 614.11 |
| PBDIT / Share (Rs.) | 53.62 | 73.54 | 60.53 | 42.76 | 60.08 |
| PBIT / Share (Rs.) | 33.13 | 54.60 | 41.03 | 26.35 | 43.98 |
| PBT / Share (Rs.) | 24.45 | 38.02 | 22.41 | 12.29 | 30.21 |
| Net Profit / Share (Rs.) | 17.18 | 25.19 | 16.00 | 7.24 | 28.52 |
| NP After MI And SOA / Share (Rs.) | 17.18 | 25.19 | 16.00 | 7.24 | 28.52 |
| PBDIT Margin (%) | 6.88 | 10.55 | 7.99 | 5.63 | 9.78 |
| PBIT Margin (%) | 4.25 | 7.83 | 5.41 | 3.47 | 7.16 |
| PBT Margin (%) | 3.14 | 5.45 | 2.96 | 1.61 | 4.91 |
| Net Profit Margin (%) | 2.20 | 3.61 | 2.11 | 0.95 | 4.64 |
| NP After MI And SOA Margin (%) | 2.20 | 3.61 | 2.11 | 0.95 | 4.64 |
| Return on Networth / Equity (%) | 6.25 | 9.77 | 7.56 | 4.04 | 16.30 |
| Return on Capital Employeed (%) | 9.64 | 15.77 | 12.73 | 7.88 | 15.02 |
| Return On Assets (%) | 3.04 | 5.05 | 3.15 | 1.36 | 5.59 |
| Long Term Debt / Equity (X) | 0.02 | 0.12 | 0.31 | 0.62 | 0.46 |
| Total Debt / Equity (X) | 0.37 | 0.34 | 0.76 | 1.04 | 0.99 |
| Asset Turnover Ratio (%) | 1.47 | 1.43 | 1.49 | 1.46 | 1.44 |
| Current Ratio (X) | 1.35 | 1.54 | 1.26 | 1.17 | 1.07 |
| Quick Ratio (X) | 0.63 | 0.77 | 0.73 | 0.67 | 0.62 |
| Inventory Turnover Ratio (X) | 5.64 | 5.05 | 6.15 | 6.25 | 5.49 |
| Interest Coverage Ratio (X) | 3.93 | 4.44 | 3.25 | 3.04 | 4.36 |
| Interest Coverage Ratio (Post Tax) (X) | 1.90 | 2.52 | 1.86 | 1.52 | 3.07 |
| Enterprise Value (Cr.) | 446.96 | 559.15 | 501.39 | 729.76 | 852.31 |
| EV / Net Operating Revenue (X) | 0.67 | 0.94 | 0.83 | 1.27 | 1.83 |
| EV / EBITDA (X) | 9.85 | 8.98 | 10.43 | 22.50 | 18.71 |
| MarketCap / Net Operating Revenue (X) | 0.51 | 0.79 | 0.59 | 0.98 | 1.52 |
| Price / BV (X) | 1.46 | 2.15 | 2.14 | 4.19 | 5.33 |
| Price / Net Operating Revenue (X) | 0.51 | 0.79 | 0.59 | 0.98 | 1.52 |
| EarningsYield | 0.04 | 0.04 | 0.03 | 0.01 | 0.03 |
After reviewing the key financial ratios for Aarti Surfactants Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 17.20. This value is within the healthy range. It has decreased from 26.63 (Mar 24) to 17.20, marking a decrease of 9.43.
- For Diluted EPS (Rs.), as of Mar 25, the value is 17.19. This value is within the healthy range. It has decreased from 25.16 (Mar 24) to 17.19, marking a decrease of 7.97.
- For Cash EPS (Rs.), as of Mar 25, the value is 37.67. This value is within the healthy range. It has decreased from 44.13 (Mar 24) to 37.67, marking a decrease of 6.46.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 274.78. It has increased from 257.64 (Mar 24) to 274.78, marking an increase of 17.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 274.78. It has increased from 257.64 (Mar 24) to 274.78, marking an increase of 17.14.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 778.53. It has increased from 696.75 (Mar 24) to 778.53, marking an increase of 81.78.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 53.62. This value is within the healthy range. It has decreased from 73.54 (Mar 24) to 53.62, marking a decrease of 19.92.
- For PBIT / Share (Rs.), as of Mar 25, the value is 33.13. This value is within the healthy range. It has decreased from 54.60 (Mar 24) to 33.13, marking a decrease of 21.47.
- For PBT / Share (Rs.), as of Mar 25, the value is 24.45. This value is within the healthy range. It has decreased from 38.02 (Mar 24) to 24.45, marking a decrease of 13.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 17.18. This value is within the healthy range. It has decreased from 25.19 (Mar 24) to 17.18, marking a decrease of 8.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 17.18. This value is within the healthy range. It has decreased from 25.19 (Mar 24) to 17.18, marking a decrease of 8.01.
- For PBDIT Margin (%), as of Mar 25, the value is 6.88. This value is below the healthy minimum of 10. It has decreased from 10.55 (Mar 24) to 6.88, marking a decrease of 3.67.
- For PBIT Margin (%), as of Mar 25, the value is 4.25. This value is below the healthy minimum of 10. It has decreased from 7.83 (Mar 24) to 4.25, marking a decrease of 3.58.
- For PBT Margin (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 10. It has decreased from 5.45 (Mar 24) to 3.14, marking a decrease of 2.31.
- For Net Profit Margin (%), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 5. It has decreased from 3.61 (Mar 24) to 2.20, marking a decrease of 1.41.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 8. It has decreased from 3.61 (Mar 24) to 2.20, marking a decrease of 1.41.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.25. This value is below the healthy minimum of 15. It has decreased from 9.77 (Mar 24) to 6.25, marking a decrease of 3.52.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.64. This value is below the healthy minimum of 10. It has decreased from 15.77 (Mar 24) to 9.64, marking a decrease of 6.13.
- For Return On Assets (%), as of Mar 25, the value is 3.04. This value is below the healthy minimum of 5. It has decreased from 5.05 (Mar 24) to 3.04, marking a decrease of 2.01.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.12 (Mar 24) to 0.02, marking a decrease of 0.10.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.37. This value is within the healthy range. It has increased from 0.34 (Mar 24) to 0.37, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.47. It has increased from 1.43 (Mar 24) to 1.47, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 1.5. It has decreased from 1.54 (Mar 24) to 1.35, marking a decrease of 0.19.
- For Quick Ratio (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has decreased from 0.77 (Mar 24) to 0.63, marking a decrease of 0.14.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.64. This value is within the healthy range. It has increased from 5.05 (Mar 24) to 5.64, marking an increase of 0.59.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.93. This value is within the healthy range. It has decreased from 4.44 (Mar 24) to 3.93, marking a decrease of 0.51.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.90. This value is below the healthy minimum of 3. It has decreased from 2.52 (Mar 24) to 1.90, marking a decrease of 0.62.
- For Enterprise Value (Cr.), as of Mar 25, the value is 446.96. It has decreased from 559.15 (Mar 24) to 446.96, marking a decrease of 112.19.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 24) to 0.67, marking a decrease of 0.27.
- For EV / EBITDA (X), as of Mar 25, the value is 9.85. This value is within the healthy range. It has increased from 8.98 (Mar 24) to 9.85, marking an increase of 0.87.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 0.79 (Mar 24) to 0.51, marking a decrease of 0.28.
- For Price / BV (X), as of Mar 25, the value is 1.46. This value is within the healthy range. It has decreased from 2.15 (Mar 24) to 1.46, marking a decrease of 0.69.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 0.79 (Mar 24) to 0.51, marking a decrease of 0.28.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Aarti Surfactants Ltd:
- Net Profit Margin: 2.2%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.64% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.25% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.9
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.63
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 21.6 (Industry average Stock P/E: 63.08)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.37
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.2%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Plot Nos. 57, 58, 60 to 64, 62A, S-3/1, Dhar District Madhya Pradesh 454775 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mulesh Manilal Savla | Chairman(NonExe.&Ind.Director) |
| Mr. Nikhil Parimal Desai | Managing Director & CEO |
| Mr. Santosh Madhaorao Kakade | Executive Director |
| Mr. Chandrakant Vallabhaji Gogri | Non Exe.Non Ind.Director |
| Mr. Dattatray Sidram Galpalli | Non Exe.Non Ind.Director |
| Mrs. Misha Bharat Gala | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Aarti Surfactants Ltd?
Aarti Surfactants Ltd's intrinsic value (as of 17 January 2026) is ₹305.23 which is 20.10% lower the current market price of ₹382.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹324 Cr. market cap, FY2025-2026 high/low of ₹653/358, reserves of ₹228 Cr, and liabilities of ₹490 Cr.
What is the Market Cap of Aarti Surfactants Ltd?
The Market Cap of Aarti Surfactants Ltd is 324 Cr..
What is the current Stock Price of Aarti Surfactants Ltd as on 17 January 2026?
The current stock price of Aarti Surfactants Ltd as on 17 January 2026 is ₹382.
What is the High / Low of Aarti Surfactants Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Aarti Surfactants Ltd stocks is ₹653/358.
What is the Stock P/E of Aarti Surfactants Ltd?
The Stock P/E of Aarti Surfactants Ltd is 21.6.
What is the Book Value of Aarti Surfactants Ltd?
The Book Value of Aarti Surfactants Ltd is 280.
What is the Dividend Yield of Aarti Surfactants Ltd?
The Dividend Yield of Aarti Surfactants Ltd is 0.26 %.
What is the ROCE of Aarti Surfactants Ltd?
The ROCE of Aarti Surfactants Ltd is 8.50 %.
What is the ROE of Aarti Surfactants Ltd?
The ROE of Aarti Surfactants Ltd is 5.14 %.
What is the Face Value of Aarti Surfactants Ltd?
The Face Value of Aarti Surfactants Ltd is 10.0.